Psychedelic Spotlight
  • News
  • Culture
  • Business
    • Business
    • News
    • Editorial
    • Stock Reports
    • Videos
    • Interviews
  • Research
  • Policy
  • PSPACE
  • Media
    • Media
    • Podcast
    • Videos
  • Work With us
    • Work With Us
    • Contact Us
    • About
  • Media Kit
  • Search
  • Menu Menu
Home1 / Psychedelic Spotlight News2 / Business3 / Videos4

Is it TOO LATE to buy MindMed? [MMEDF] 🍄

byPsychedelic SpotlightonNovember 25, 2020
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn

MindMed (MMEDF/MMED) stock EXPLODED in the past week which raises the question: Is it too late to BUY MindMed stock? Watch the video as I provide my insight on some factors you might want to consider. 💯

Music: www.bensound.com
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

Have you heard about our new community?

We’re excited to announce Bonfire -
a personal growth community
for people who are interested in psychedelics.

Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.

Sign Up Here

Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.

Explore

  • About
  • Treatment
  • Work With Us
  • News
  • Privacy Policy
  • Terms and Conditions

Resources

  • Conferences
  • Experts
  • Glossary
  • Therapy

Subscribe

           

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.
Peter Thiel Invests $12 Million In Psychedelic Drug ManufacturerPeter Thiel Invests $12 Million In Psychedelic Drug ManufacturerWhy Is DMT Called The Spirit MoleculeWhy Is DMT Called The Spirit Molecule?
Scroll to top

Get a roundup of Psychedelic news stories in your inbox

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Hidden
Which list would you like to subscribe to?
Enter your email below to subscribe to Psychedelic News.